Decision Resources’ findings, based on the Pharmacor topic “Prostate Cancer,” revealed that the launches of several promising emerging therapies for prostate cancer will drive the market’s growth from $3.6 billion in 2010 to almost three times that amount over the next 10 years.
Related Articles on Hospital Oncology:
Prostate Cancer Patients May See Better Outcomes at Academic Hospitals
Kansas’ Via Christi Hospital Joins Midwest Cancer Alliance
Barnes-Jewish Hospital Installs First-of-its-Kind Proton Accelerator
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
